Li Meng, Yuan Haodan, Li Na, Song Guotao, Zheng Yi, Baratta Mike, Hua Fengmei, Thurston Archie, Wang Joanne, Lai Yurong
Department of Pharmacokinetics, Pfizer Global Research & Development, St. Louis, MO, USA.
Eur J Pharm Sci. 2008 Sep 2;35(1-2):114-26. doi: 10.1016/j.ejps.2008.06.008. Epub 2008 Jun 28.
The large interspecies differences of hepatobiliary transport present a challenge for the allometric prediction of human biliary excretion for drug candidates primarily cleared via hepatobiliary secretion. In the present study, we determined the metabolic stabilities of common fluorescent substrates of hepatobiliary efflux transporters and developed a rapid efflux assay to determine the functional activities of MRP/Mrp, BCRP/Bcrp and P-gp in hepatocytes of four species. The specificities of transporter-mediated dye efflux were confirmed by selective transporter inhibitors. Among tested species, transporter-specific dye efflux kinetics was consistent between freshly isolated and cryopreserved hepatocytes. Hepatocyte elimination half-lives of MRP/Mrp substrates GS-MF and calcein were observed in the rank order of human>monkey>dog>rat. The fourfold higher MRP/Mrp substrate efflux rate of rat hepatocytes compared to human is likely due to the species-specific functional differences of MRP2/Mrp2 expressed on the canalicular membrane. We also observed efficient BCRP-mediated pheophorbide A (PhA) efflux by human and dog hepatocytes, while PhA extrusion in monkey and rat hepatocytes appeared limited. P-gp function measured by DiOC2(3) efflux was minimal in hepatocytes of all origins and no significant species differences were detected. Our results demonstrated marked differences in hepatocyte MRP/Mrp and BCRP/Bcrp activities across species, indicating that they may contribute to the species differences of in vivo hepatobiliary excretion. These results also suggest the potential utility of primary hepatocytes, either fresh or cryopreserved, as an in vitro model to predict interspecies differences in the biliary transport of MRP/Mrp and BCRP/Bcrp substrates.
肝胆转运存在的种间差异巨大,这对主要通过肝胆分泌清除的候选药物的人体胆汁排泄的异速生长预测构成了挑战。在本研究中,我们测定了肝胆外排转运体常见荧光底物的代谢稳定性,并开发了一种快速外排测定法,以确定四种物种肝细胞中MRP/Mrp、BCRP/Bcrp和P-糖蛋白的功能活性。转运体介导的染料外排特异性通过选择性转运体抑制剂得以证实。在受试物种中,新鲜分离的肝细胞和冻存肝细胞之间的转运体特异性染料外排动力学是一致的。观察到MRP/Mrp底物GS-MF和钙黄绿素在肝细胞中的消除半衰期顺序为人类>猴子>狗>大鼠。大鼠肝细胞的MRP/Mrp底物外排率比人类高四倍,这可能是由于胆小管膜上表达的MRP2/Mrp2存在物种特异性功能差异。我们还观察到人类和狗的肝细胞能有效介导BCRP介导的脱镁叶绿酸A(PhA)外排,而猴子和大鼠肝细胞中的PhA外排似乎有限。通过DiOC2(3)外排测定的P-糖蛋白功能在所有来源的肝细胞中都很微弱,未检测到明显的物种差异。我们的结果表明,不同物种的肝细胞中MRP/Mrp和BCRP/Bcrp活性存在显著差异, 这表明它们可能导致体内肝胆排泄的物种差异。这些结果还表明,新鲜或冻存的原代肝细胞作为预测MRP/Mrp和BCRP/Bcrp底物胆汁转运种间差异的体外模型具有潜在用途。